82 FR 15526 - Request for Information for the Development of the Fiscal Year 2019 Trans-NIH Plan for HIV-Related Research
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 82, Issue 59 (March 29, 2017)
National Institutes of Health
Federal Register Volume 82, Issue 59 (March 29, 2017)
| Page Range | 15526-15526 | |
| FR Document | 2017-06183 |
[Federal Register Volume 82, Number 59 (Wednesday, March 29, 2017)] [Notices] [Page 15526] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-06183] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Request for Information for the Development of the Fiscal Year 2019 Trans-NIH Plan for HIV-Related Research SUMMARY: Through this Request for Information (RFI), the Office of AIDS Research (OAR) in the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), National Institutes of Health (NIH), invites feedback from investigators in academia, industry, health care professionals, patient advocates and health advocacy organizations, scientific or professional organizations, federal agencies, community, and other interested constituents on the development of the fiscal year (FY) 2019 Trans-NIH Plan for HIV-Related Research (FY 2019 AIDS Research Plan). This plan is designed to identify and articulate future directions to maximize the NIH's investments in HIV/AIDS research. DATES: The OAR's Request for Information is open for public comment for a period of 45 days. Comments must be received by May 15, 2017 to ensure consideration. After the public comment period has closed, the comments received by the OAR will be considered in a timely manner for the development of the FY2019 AIDS Research Plan. ADDRESSES: Submissions may be electronically sent to http://grants.nih.gov/grants/rfi/rfi.cfm?ID=63 or, if needed, by mail to Paul Gaist, Ph.D., M.P.H. Office of AIDS Research, National Institutes of Health, Room 2E40, 5601 Fishers Lane, Rockville, Maryland 20852. FOR FURTHER INFORMATION CONTACT: Questions about this request for information should be directed to Paul Gaist, Ph.D., M.P.H. Office of AIDS Research, National Institutes of Health Email: [email protected] or if needed, by mail to Room 2E40, 5601 Fishers Lane, Rockville, Maryland 20852. SUPPLEMENTARY INFORMATION: To access and respond to the RFI, go to the following Web address: http://grants.nih.gov/grants/rfi/rfi.cfm?ID=63. OAR oversees and coordinates the conduct and support of all HIV/ AIDS research activities across the NIH Institutes and Centers (ICs). The NIH-sponsored HIV/AIDS research program includes both extramural and intramural research, buildings and facilities, research training, program evaluation, and supports a comprehensive portfolio of research representing a broad range of basic, clinical, behavioral, social science, and translational research on HIV/AIDS and its associated coinfections and comorbidities. OAR plans and coordinates research through the development of an annual Trans-NIH Plan for HIV-Related Research that articulates the overarching HIV/AIDS research priorities and serves as the framework for developing the trans-NIH HIV/AIDS research budget. This Plan provides information about the NIH's HIV/AIDS research priorities to the scientific community, Congress, community stakeholders, HIV- affected communities, and the broad public at large. The fiscal year 2018 Trans-NIH Plan for HIV-Related Research was recently distributed on the OAR Web site: (https://www.oar.nih.gov/strategic_plan/plan_18.asp). New overarching priorities for HIV/AIDS research were defined in the NIH Director's Statement of August 12, 2015 (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-137.html). High Priority topics of research for support include: (1) Reducing the incidence of HIV/AIDS; (2) Developing the next generation of HIV therapies; (3) Identifying strategies towards a cure; (4) Improving the prevention and treatment of HIV-associated comorbidities, coinfections, and complications; and (5) Cross-cutting basic research, behavioral and social science research, health disparities, and training. This RFI is for planning purposes only and should not be construed as a solicitation for applications or proposals, or as an obligation in any way on the part of the United States federal government. The federal government will not pay for the preparation of any information submitted or for the government's use. Additionally, the government cannot guarantee the confidentiality of the information provided. Dated: March 23, 2017. Lawrence A. Tabak, Deputy Director, National Institutes of Health. [FR Doc. 2017-06183 Filed 3-28-17; 8:45 am] BILLING CODE 4140-01-P
![15526 Federal Register / Vol. 82, No. 59 / Wednesday, March 29, 2017 / Notices
Date: April 21, 2017. National Institutes of Health, Room This RFI is for planning purposes
Time: 9:30 a.m. to 4:30 p.m. 2E40, 5601 Fishers Lane, Rockville, only and should not be construed as a
Agenda: To review and evaluate grant Maryland 20852. solicitation for applications or
applications.
FOR FURTHER INFORMATION CONTACT: proposals, or as an obligation in any
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, Questions about this request for way on the part of the United States
Contact Person: Xiang-Ning Li, MD, Ph.D., information should be directed to Paul federal government. The federal
Scientific Review Officer, Center for Gaist, Ph.D., M.P.H. Office of AIDS government will not pay for the
Scientific Review, National Institutes of Research, National Institutes of Health preparation of any information
Health, 6701 Rockledge Drive, Room 5112, Email: ODOARRFI19@nih.gov or if submitted or for the government’s use.
MSC 7854, Bethesda, MD 20892, 301–435– needed, by mail to Room 2E40, 5601 Additionally, the government cannot
1744, lixiang@csr.nih.gov. guarantee the confidentiality of the
Fishers Lane, Rockville, Maryland
(Catalogue of Federal Domestic Assistance 20852. information provided.
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333, SUPPLEMENTARY INFORMATION: To access Dated: March 23, 2017.
93.337, 93.393–93.396, 93.837–93.844, and respond to the RFI, go to the Lawrence A. Tabak,
93.846–93.878, 93.892, 93.893, National following Web address: http://grants. Deputy Director, National Institutes of Health.
Institutes of Health, HHS) nih.gov/grants/rfi/rfi.cfm?ID=63. [FR Doc. 2017–06183 Filed 3–28–17; 8:45 am]
Dated: March 23, 2017. OAR oversees and coordinates the BILLING CODE 4140–01–P
David Clary, conduct and support of all HIV/AIDS
Program Analyst, Office of Federal Advisory research activities across the NIH
Committee Policy. Institutes and Centers (ICs). The NIH- DEPARTMENT OF HEALTH AND
[FR Doc. 2017–06147 Filed 3–28–17; 8:45 am] sponsored HIV/AIDS research program HUMAN SERVICES
BILLING CODE 4140–01–P
includes both extramural and
intramural research, buildings and National Institutes of Health
facilities, research training, program
National Center for Advancing
DEPARTMENT OF HEALTH AND evaluation, and supports a
Translational Sciences; Notice of
HUMAN SERVICES comprehensive portfolio of research
Meetings
representing a broad range of basic,
National Institutes of Health clinical, behavioral, social science, and Pursuant to section 10(d) of the
translational research on HIV/AIDS and Federal Advisory Committee Act, as
Request for Information for the its associated coinfections and amended (5 U.S.C. App.), notice is
Development of the Fiscal Year 2019 comorbidities. hereby given of meetings of the National
Trans-NIH Plan for HIV-Related OAR plans and coordinates research Center for Advancing Translational
Research through the development of an annual Sciences.
SUMMARY: Through this Request for Trans-NIH Plan for HIV-Related The meetings will be open to the
Information (RFI), the Office of AIDS Research that articulates the overarching public as indicated below, with
Research (OAR) in the Division of HIV/AIDS research priorities and serves attendance limited to space available.
Program Coordination, Planning, and as the framework for developing the Individuals who plan to attend and
Strategic Initiatives (DPCPSI), National trans-NIH HIV/AIDS research budget. need special assistance, such as sign
Institutes of Health (NIH), invites This Plan provides information about language interpretation or other
feedback from investigators in the NIH’s HIV/AIDS research priorities reasonable accommodations, should
academia, industry, health care to the scientific community, Congress, notify the Contact Person listed below
professionals, patient advocates and community stakeholders, HIV-affected in advance of the meeting.
health advocacy organizations, scientific communities, and the broad public at The meetings will be closed to the
or professional organizations, federal large. The fiscal year 2018 Trans-NIH public in accordance with the
agencies, community, and other Plan for HIV-Related Research was provisions set forth in sections
interested constituents on the recently distributed on the OAR Web 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
development of the fiscal year (FY) 2019 site: (https://www.oar.nih.gov/strategic_ as amended. The grant applications and
Trans-NIH Plan for HIV-Related plan/plan_18.asp). the discussions could disclose
Research (FY 2019 AIDS Research Plan). New overarching priorities for HIV/ confidential trade secrets or commercial
This plan is designed to identify and AIDS research were defined in the NIH property such as patentable material,
articulate future directions to maximize Director’s Statement of August 12, 2015 and personal information concerning
the NIH’s investments in HIV/AIDS (https://grants.nih.gov/grants/guide/ individuals associated with the grant
research. notice-files/NOT-OD-15-137.html). applications, the disclosure of which
High Priority topics of research for would constitute a clearly unwarranted
DATES: The OAR’s Request for support include: invasion of personal privacy.
Information is open for public comment (1) Reducing the incidence of HIV/ Name of Committee: Cures Acceleration
for a period of 45 days. Comments must AIDS; Network Review Board.
be received by May 15, 2017 to ensure (2) Developing the next generation of Date: May 4, 2017.
consideration. After the public comment HIV therapies; Time: 8:30 a.m. to 2:30 p.m.
period has closed, the comments (3) Identifying strategies towards a Agenda: Report from the Institute Director.
received by the OAR will be considered cure; Place: National Institutes of Health,
mstockstill on DSK3G9T082PROD with NOTICES
in a timely manner for the development (4) Improving the prevention and Building 31, Conference Room 6, 31 Center
of the FY2019 AIDS Research Plan. treatment of HIV-associated Drive, Bethesda, MD 20892.
Contact Person: Anna L. Ramsey-Ewing,
ADDRESSES: Submissions may be comorbidities, coinfections, and Ph.D., Executive Secretary, National Center
electronically sent to http:// complications; and for Advancing Translational Sciences, 1
grants.nih.gov/grants/rfi/rfi.cfm?ID=63 (5) Cross-cutting basic research, Democracy Plaza, Room 1072, Bethesda, MD
or, if needed, by mail to Paul Gaist, behavioral and social science research, 20892, 301–435–0809, anna.ramseyewing@
Ph.D., M.P.H. Office of AIDS Research, health disparities, and training. nih.gov.
VerDate Sep<11>2014 16:54 Mar 28, 2017 Jkt 241001 PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 E:\FR\FM\29MRN1.SGM 29MRN1](https://thefederalregister.org/doc/82_FR_15585/page/1.svg)
Document Created: 2017-03-29 01:14:40
Document Modified: 2017-03-29 01:14:40
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | The OAR's Request for Information is open for public comment for a period of 45 days. Comments must be received by May 15, 2017 to ensure consideration. After the public comment period has closed, the comments received by the OAR will be considered in a timely manner for the development of the FY2019 AIDS Research Plan. | |
| Contact | Questions about this request for information should be directed to Paul Gaist, Ph.D., M.P.H. Office of AIDS Research, National Institutes of Health Email: [email protected] or if needed, by mail to Room 2E40, 5601 Fishers Lane, Rockville, Maryland 20852. | |
| FR Citation | 82 FR 15526 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR